The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis.

Background and Purpose: Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) phenotype is highly variable, and, although the full clinical-neuroimaging picture may be suggestive of the disease, no characteristic is pathognomonic. Thus, a genetic test r...

Descripción completa

Detalles Bibliográficos
Publicado en:Stroke (00392499) Vol. 43; no. 11; pp. 2871 - 2877
Autores principales: Pescini F, Nannucci S, Bertaccini B, Salvadori E, Bianchi S, Ragno M, Sarti C, Valenti R, Zicari E, Moretti M, Chiti S, Stromillo ML, De Stefano N, Dotti MT, Federico A, Inzitari D, Pantoni L, Pescini, Francesca, Nannucci, Serena, Bertaccini, Bruno
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins Nov2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108073530&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108073530
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00392499
        1FT
      jtl: Stroke (00392499)
      issn: 00392499
      maglogo: N
    pubinfo:
      dt: Nov2012
      vid: 43
      iid: 11
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        108073530
        NLM22996955
        2011724714
        10.1161/STROKEAHA.112.665927
        NLM22996955
        108073530
      ppf: 2871
      ppct: 6
      formats:
      tig:
        atl: The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis.
      aug:
        au:
          Pescini F
          Nannucci S
          Bertaccini B
          Salvadori E
          Bianchi S
          Ragno M
          Sarti C
          Valenti R
          Zicari E
          Moretti M
          Chiti S
          Stromillo ML
          De Stefano N
          Dotti MT
          Federico A
          Inzitari D
          Pantoni L
          Pescini, Francesca
          Nannucci, Serena
          Bertaccini, Bruno
        affil: Department of Neurological and Psychiatric Sciences, University of Florence, and Department of Radiology, Neuroradiology Unit, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy
      sug:
        subj:
          Algorithms
          CADASIL Diagnosis
          Genetic Screening Methods
          Receptors, Cell Surface
          Human
          ROC Curve
          Sensitivity and Specificity
      ab: Background and Purpose: Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) phenotype is highly variable, and, although the full clinical-neuroimaging picture may be suggestive of the disease, no characteristic is pathognomonic. Thus, a genetic test remains the diagnostic gold standard, but because it is costly and time-consuming, a pregenetic screening appears desirable. We aimed at developing the CADASIL scale, a screening tool to be applied in the clinical setting. Methods: A preliminary scale was created assigning weighted scores to common disease features based on their frequencies obtained in a pooled analysis of selected international CADASIL series. The accuracy of the scale versus the genetic diagnosis was tested with receiver operating characteristic analysis after the application of this scale to 61 CADASIL and 54 NOTCH3-negative patients (no pathogenic mutation on exons 2-23 of the NOTCH3 gene). To improve the scale accuracy, we then developed an ad hoc optimization algorithm to detect the definitive scale. A third group of 39 patients affected by sporadic small-vessel disease was finally included in the algorithm to evaluate the stability of the scale. Results: The cutoff score of the definitive CADASIL scale had a sensitivity of 96.7% and a specificity of 74.2%. This scale was robust to contamination of patients with sporadic small-vessel disease. Conclusions: The CADASIL scale is a simple and sufficiently accurate screening tool to select patients with a high probability to be affected by the disease and therefore to be subjected to the genetic testing.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N